[BREAKING] [NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.

6 December Share

[BREAKING] [NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.

[ NEWS ] [ SENS ] The FDA approval of Sensonics Holdings has been delayed . This is expected to interfere with profits for the time being , and the next application is scheduled for 2023 in two years .

[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.

[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.

[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years. [More News]